InvestorsHub Logo
icon url

Biobillionair

07/26/13 2:26 PM

#11349 RE: Biobillionair #11345

Amarin attempted to patent an Epanova like free fatty acid, 13685281. It received a final rejection 7-22 and mailed final rejection today.

It was rejected on the basis of double patenting, it conflicted and was obvious to Amarins current patents. Epanova can NEVER get IP protection.

Congrats Amarin, your IP got stronger today.

Williams
icon url

BiotechWill

07/26/13 4:45 PM

#11375 RE: Biobillionair #11345

Sorry if my last post was a little less than polite BioB - like many, I've been getting extremely frustrated over a lot of the lies, misconceptions, bashing, etc - and I think I had my fill a bit earlier.

As always, my goal is to help everyone with understanding and learning, and also to gain in understanding and learning from others. Using "smack down" language and other sorts of common vernacular in a logical argument was out of line.

That said, thanks for sharing the post on the patent - I appreciate the way you monitor the FDA like a new parent watching an infant sleep at home the first night! Have a good weekend.